Minerva Surgical, Inc. (NASDAQ:UTRS) has rebounded strongly over the last week, with the share price soaring 51%. But that isn't much consolation for the painful drop we've seen in the last year. To ...

Additionally, Minerva ES is a one-time, non-hormonal, incisionless treatment with the recovery time of 1-2 days. "The agreement with Minerva Surgical is important to Blackmaple Group because it ...

Short interest for Minerva Surgical gives investors a sense of the degree to which investors are betting on the decline of Minerva Surgical's stock. Short interest data is updated every two weeks.

In January, Minerva Surgical lost a patent infringement suit against Hologic, a rival manufacturer of a radiofrequency device for treating heavy bleeding in the uterus. But Minerva hasn’t raised the ...

SANTA CLARA, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women’s health company focused on the treatment of Abnormal Uterine ...

SANTA CLARA, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on the treatment of Abnormal Uterine ...

SANTA CLARA, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on solutions to meet the distinct ...

SANTA CLARA, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Minerva Surgical), a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today announced ...